The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Immunovaccine
Stock and Other Ownership Interests - Immunovaccine
 
Stock and Other Ownership Interests - Abbott; Abbvie; Bristol-Myers Squibb; Intuitive Surgical; Johnson & Johnson; Merck
Consulting or Advisory Role - Tempus
Clinical data from the DeCidE1 trial: Assessing the first combination of DPX-Survivac, low dose cyclophosphamide (CPA), and epacadostat (INCB024360) in subjects with stage IIc-IV recurrent epithelial ovarian cancer.
 
Oliver Dorigo
Honoraria - Geneos; Myriad Genetics; Neutar; Tesaro
Consulting or Advisory Role - Geneos; Myriad Genetics; Neutar
Speakers' Bureau - Tesaro
Research Funding - Aduro Biotech (Inst); Immunovaccine (Inst); Millennium (Inst)
Travel, Accommodations, Expenses - Geneos; Myriad Genetics; Neutar; Tesaro
 
Janos Laszlo Tanyi
No Relationships to Disclose
 
James Strauss
No Relationships to Disclose
 
Amit M. Oza
Honoraria - Intas
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Tanja Pejovic
No Relationships to Disclose
 
Prafull Ghatage
No Relationships to Disclose
 
Jeannine A. Villella
Employment - Lenox Hill Hospital; Northwell Health
 
Stephan Fiset
No Relationships to Disclose
 
Lisa Diana MacDonald
Employment - Immunovaccine
Stock and Other Ownership Interests - Immunovaccine
 
Lance Leopold
Employment - Incyte
Leadership - Incyte
Stock and Other Ownership Interests - Incyte
 
Gabriela Nicola Rosu
Employment - Immunovaccine
Leadership - Immunovaccine
Stock and Other Ownership Interests - Immunovaccine
Patents, Royalties, Other Intellectual Property - I am employed and own stock options in Immunovaccine Inc which owns Depovax and DPX Survivac
Travel, Accommodations, Expenses - Immunovaccine